Skip to main content
TipRanks
Go Ultimate75% OFF

PT Wahana Pronatural Tbk (WAPO) Ratios

PT Wahana Pronatural Tbk Ratios

ID:WAPO's free cash flow for Q2 2026 was Rp-438.46M. For the 2026 fiscal year, ID:WAPO's free cash flow was decreased by Rp-240.00M and operating cash flow was Rp-198.46M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Dec 24Mar 24Mar 23Dec 21
Liquidity Ratios
Current Ratio1.572.891.432.082.23
Quick Ratio1.022.071.281.551.54
Cash Ratio0.200.790.160.120.19
Solvency Ratio-0.330.100.01-0.110.05
Operating Cash Flow Ratio-0.240.250.16-0.07-0.04
Short-Term Operating Cash Flow Coverage-212.22106.110.000.000.00
Net Current Asset ValueRp 15.25BRp 25.03BRp 25.10BRp 27.14BRp 29.51B
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.491.201.851.371.34
Debt Service Coverage Ratio-399.3244.280.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.030.080.020.040.20
Net Debt to EBITDA0.43-1.93-93.710.906.45
Profitability Margins
Gross Profit Margin1.27%1.13%2.83%0.51%0.42%
EBIT Margin-1.05%0.23%-0.09%-1.31%-1.15%
EBITDA Margin-0.91%0.26%0.02%-0.98%-0.22%
Operating Profit Margin-1.05%0.02%-0.09%-1.47%-1.14%
Pretax Profit Margin-0.82%0.23%0.16%-1.31%-0.46%
Net Profit Margin-0.81%0.03%0.05%-1.23%-0.50%
Continuous Operations Profit Margin-0.81%0.03%0.05%-1.23%-0.50%
Net Income Per EBT98.37%14.88%33.28%93.96%109.46%
EBT Per EBIT78.26%930.93%-183.02%89.21%40.48%
Return on Assets (ROA)-12.92%0.83%0.17%-4.17%-1.59%
Return on Equity (ROE)-19.27%1.00%0.31%-5.73%-2.13%
Return on Capital Employed (ROCE)-24.58%0.71%-0.50%-6.76%-4.75%
Return on Invested Capital (ROIC)-24.17%0.11%-0.17%-6.35%-4.75%
Return on Tangible Assets-12.92%0.83%0.17%-4.17%-1.59%
Earnings Yield-5.20%0.43%0.21%-1.31%-0.70%
Efficiency Ratios
Receivables Turnover78.46137.386.448.9710.01
Payables Turnover62.42155.566.8913.2213.84
Inventory Turnover89.78186.4744.3423.9518.44
Fixed Asset Turnover226.83282.8572.92107.8721.72
Asset Turnover15.9724.513.193.383.16
Working Capital Turnover Ratio68.0682.0415.6711.3410.60
Cash Conversion Cycle2.872.2711.9828.3329.87
Days of Sales Outstanding4.652.6656.6940.7036.45
Days of Inventory Outstanding4.071.968.2315.2419.79
Days of Payables Outstanding5.852.3552.9427.6126.38
Operating Cycle8.724.6164.9255.9456.25
Cash Flow Ratios
Operating Cash Flow Per Share-5.532.768.39-1.40-0.89
Free Cash Flow Per Share-5.550.895.83-1.40-0.89
Dividend Paid and CapEx Coverage Ratio-265.781.473.270.000.00
Capital Expenditure Coverage Ratio-265.781.473.270.000.00
Operating Cash Flow Coverage Ratio-212.2236.12458.05-32.33-4.50
Operating Cash Flow to Sales Ratio-0.000.000.02-0.01-0.00
Free Cash Flow Yield-3.08%0.65%6.40%-0.56%-0.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-19.23234.48478.95-76.22-143.41
Price-to-Sales (P/S) Ratio0.160.080.250.940.72
Price-to-Book (P/B) Ratio3.702.341.474.373.06
Price-to-Free Cash Flow (P/FCF) Ratio-32.43153.5915.62-179.20-207.65
Price-to-Operating Cash Flow Ratio-32.5549.1910.84-179.20-207.65
Price-to-Earnings Growth (PEG) Ratio0.011.14-4.53-0.49-15.38
Enterprise Value Multiple-16.6228.51920.02-94.77-324.45
Enterprise Value217.74B158.09B94.78B307.30B225.10B
EV to EBITDA-16.6228.51920.02-94.77-324.45
EV to Sales0.150.070.230.930.71
EV to Free Cash Flow-31.61143.8714.17-177.51-203.61
EV to Operating Cash Flow-31.7346.079.84-177.51-203.61
Tangible Book Value Per Share48.5958.0562.0857.2360.49
Shareholders’ Equity Per Share48.5958.0562.0857.2360.49
Tax and Other Ratios
Effective Tax Rate0.020.850.670.06-0.09
Revenue Per Share1157.251710.28366.79265.95255.61
Net Income Per Share-9.360.580.19-3.28-1.29
Tax Burden0.980.150.330.941.09
Interest Burden0.781.00-1.831.000.40
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.020.010.030.030.02
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.594.7744.070.430.69

Currency in IDR